Indacaterol(in da ka’ ter ol)
Arcapta Neohaler
PREGNANCY CATEGORY C
Drug Classes
Beta2 agonist, long-acting
Bronchodilator
Therapeutic Actions
Long-acting agonist that binds to beta2 receptors in the lungs, causing bronchodilation; may also inhibit the release of inflammatory mediators in the lungs, blocking swelling and inflammation.
Indications
Long-term maintenance for treatment of airflow obstruction in patients with COPD, including chronic bronchitis and emphysema
Contraindications and Cautions
Contraindicated with history of serious hypersensitivity reactions to indacaterol, asthma, deteriorating COPD.
Use cautiously with convulsive disorders, thyrotoxicosis, CV disorders, known sensitivity to sympathomimetics, pregnancy, lactation.
Available Forms
Inhalation powder—75 mcg
Dosages
Adults
75 mcg/day by oral inhalation using the Neohaler only.
Pediatric patients
Not recommended.
Pharmacokinetics
|
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
